Last reviewed · How we verify

NCT02988063

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Withdrawn Phase 4 Last updated 15 September 2017
What this trial tests

Phase 4 trial testing Polidocanol Endovenous Microfoam (PEM) in Leg Ulcer. Withdrawn.

Timeline
10 April 2017
Primary endpoint
12 September 2017
12 September 2017

Quick facts

Lead sponsorOhioHealth
PhasePhase 4
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date10 April 2017
Primary completion12 September 2017
Estimated completion12 September 2017
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

OhioHealth — full company profile →

Who can join

18 and older, any sex, with Leg Ulcer or Veins, Varicose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the addition of polidocanol endovenous microfoam (PEM) to compression therapy to determine effectiveness in improving the healing of venous leg ulcers (VLUs) in adults with severe venous disease of the great saphenous vein (GSV). All participants will receive treatment with Varithena and compression therapy. The purpose of this study is to assess whether the use of PEM to correct superficial axial and varicose vein reflux is effective in improving healing of VLUs, over treatment with compression alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Leg Ulcer

Currently open trials in the same condition.

Other OhioHealth trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02988063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing